Advertisement
biocon share price

Biocon share price

 

More Stories on Biocon share price
Biocon concludes Rs 4,150 crore QIP; SBI Mutual Fund among 39 investors

Biocon concludes Rs 4,150 crore QIP; SBI Mutual Fund among 39 investors

Jan 15, 2026, 09:24 AM IST

Biocon said the proceeds would be primarily used to meet the cash consideration payable to Mylan Inc, now Viatris, for the acquisition of its shareholding in Biocon Biologics Ltd.

Biocon shares in focus as drugmaker opens QIP; check details

Biocon shares in focus as drugmaker opens QIP; check details

Jan 13, 2026, 08:30 AM IST

This floor price is at a premium to the stock's recent performance. On Monday, shares of Biocon settled 2 per cent lower at Rs 372.05 on the BSE.

Biocon gets USFDA approval for Everolimus tablets; check stock reaction

Biocon gets USFDA approval for Everolimus tablets; check stock reaction

Jan 12, 2026, 09:35 AM IST

In an exchange filing, the company said the approval covers Everolimus Tablets for Oral Suspension in 2 mg, 3 mg and 5 mg strengths.

Biocon to fully merge Biocon Biologics; board approves fundraise up to Rs 4,500 crore

Biocon to fully merge Biocon Biologics; board approves fundraise up to Rs 4,500 crore

Dec 06, 2025, 12:21 PM IST

Separately, Biocon will buy the residual stake held by Mylan Inc. (Viatris) for an aggregate consideration disclosed as USD 815 million, of which USD 400 million will be paid in cash.

Biocon clarifies on reports of possible merger, IPO plans for Biocon Biologics

Biocon clarifies on reports of possible merger, IPO plans for Biocon Biologics

Nov 14, 2025, 09:12 AM IST

Biocon reiterated that the internal review is ongoing. "Accordingly, the Committee constituted as aforesaid is still evaluating the best value creation option," the company said.

Biocon shares up 10% in 2 days post Q2 show; Brokerages see further upside; check targets

Biocon shares up 10% in 2 days post Q2 show; Brokerages see further upside; check targets

Nov 13, 2025, 11:41 AM IST

JM Financial reiterated its ‘Buy’ rating, citing confidence in the company’s outlook, biosimilar scale-up and deleveraging efforts. It has raised its 12-month target price.

Pharma tariff: Aurobindo, Lupin, DRL, Sun, Zydus, Biocon in focus after 100% Trump tariff

Pharma tariff: Aurobindo, Lupin, DRL, Sun, Zydus, Biocon in focus after 100% Trump tariff

Sep 26, 2025, 07:51 AM IST

Trump tariff: US exports as percentage of Biocon's sales stands at 46 per cent. Cipla (29 per cent), Dr Reddy's Labs (46 p cent), Lupin (36 per cent) and Sun Pharma (33 per cent), are other pharma exporters to the US.

Biocon shares in focus as it opens manufacturing facility in New Jersey

Biocon shares in focus as it opens manufacturing facility in New Jersey

Sep 11, 2025, 08:32 AM IST

Biocon shares are up 7 per cent in the past one month, which helped the stock trim its year-to-date loses to 1 per cent.

Bajaj Housing Finance, LTIMindTree, Biocon: How to trade these 3 buzzing stocks

Bajaj Housing Finance, LTIMindTree, Biocon: How to trade these 3 buzzing stocks

Apr 23, 2025, 07:26 AM IST

An analyst from Axis Securities said that Bajaj Housing has formed a higher top and a higher bottom on the daily charts, which confirms a short-term trend reversal.

Eicher Motors, Tata Consumer, Biocon & Chambal Fertilisers: 4 stock picks by SMC Global

Eicher Motors, Tata Consumer, Biocon & Chambal Fertilisers: 4 stock picks by SMC Global

Jan 27, 2025, 10:31 AM IST

SMC Global Securities said that Eicher Motors has been trading within a well-defined channel, and a breakout has occurred on the daily chart, indicating a significant shift in its price momentum.

Biocon shares near Sept 2024 high as HSBC upgrades stock to buy; here's target price

Biocon shares near Sept 2024 high as HSBC upgrades stock to buy; here's target price

Jan 14, 2025, 03:24 PM IST

Biocon target price: HSBC's base case target suggests 10 per cent upside over the prevailing stock price. Its bull case target suggests 40 per cent surge while the bear case target hints at 36 per cent downside ahead.